Pfizer Corporation

Saturu Iguchi

Chikara Uchida

Koji Ando

Toyoharu Numata

Noriaki Murase

Yoshinori Murata

Hiroki Sone

Tatsuo Ueki

This invention relates to compounds of the formula (I): wherein R, R, R, A and m are each as described herein or a pharmaceutically acceptable salt or solvate thereof, and compositions containing such compounds and the use of such compounds in the treatment of a condition mediated by 5-HTreceptor activity such as, but not limited to, gastroesophageal reflux disease, gastrointestinal disease, gastric motility disorder, non-ulcer dyspepsia, functional dyspepsia, irritable bowel syndrome (IBS), constipation, dyspepsia, esophagitis, gastroesophageral disease, nausea, central nervous system disease, Alzheimer's disease, cognitive disorder, emesis, migraine, neurological disease, pain, cardiovascular disorders such as cardiac failure and heart arrhythmia, diabetes and apnea syndrome.

Benzimidazolone carboxylic acid derivatives

Growing community of inventors

Chita-gun, Japan

Saturu Iguchi